Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03466060 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of 3 Contact Lens Materials With 3 Solution Types
A NA study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 130
- Enrollment target
NCT03466060: Completed NA study, sponsored by Johnson & Johnson Vision Care.
NCT03466060 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 130 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03466060, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 130 participants
- Enrollment target
Study Summary
This is a multi-site, randomized, double-masked, contralateral, 2 treatment x 2 period crossover, dispensing, five-visit study to gain clinical insights of the study lenses and solutions.
Primary Outcome
Subjective assessment of initial comfort was conducted using Visual Analogue Scale (VAS) of comfort. VAS of comfort consists of a vertical line which represents continuous scale from 0 (extremely uncomfortable) to 100 (extremely comfortable). VAS comfort was measured at 1-min, 5-min, 45-min, and 2-hours post-fit. The average comfort score for each solution was reported. This is a contralateral crossover, subject used the revitalens solution in one eye throughout the entire study therefore there
Interventions
- DEVICE Opti-Free : RevitaLens / Clear Care : RevitaLens
- DEVICE Opti-Free : RevitaLens / RevitaLens : Clear Care
- DEVICE Clear Care : RevitaLens/ Opti-Free : RevitaLens
- DEVICE Clear Care : RevitaLens / RevitaLens : Opti-Free
- DEVICE RevitaLens : Clear Care/ Opti-Free : RevitaLens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2018-02-07 |
| Est. Completion | 2018-06-19 |
| Phase | NA |
What the finished NCT03466060 record still lists
NCT03466060 is an interventional study that assigns participants to a tested intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 5 interventions - of which Opti-Free : RevitaLens / Clear Care : RevitaLens is the first listed.
NCT03466060 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03466060 about?
NCT03466060 is a clinical study titled "Clinical Evaluation of 3 Contact Lens Materials With 3 Solution Types". This is a multi-site, randomized, double-masked, contralateral, 2 treatment x 2 period crossover, dispensing, five-visit study to gain clinical insights of the study lenses and solutions.
What is the current status of trial NCT03466060?
This trial is currently completed. It is a NA study. The enrollment target is 130 participants. The study started on 2018-02-07. Estimated completion is 2018-06-19.
What interventions are being tested in trial NCT03466060?
The interventions under investigation include: Opti-Free : RevitaLens / Clear Care : RevitaLens (DEVICE), Opti-Free : RevitaLens / RevitaLens : Clear Care (DEVICE), Clear Care : RevitaLens/ Opti-Free : RevitaLens (DEVICE), Clear Care : RevitaLens / RevitaLens : Opti-Free (DEVICE), RevitaLens : Clear Care/ Opti-Free : RevitaLens (DEVICE).
Who is sponsoring clinical trial NCT03466060?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03466060's enrollment target sits among peer trials
130 733rd of 2000 higher than 1,257 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492036 · 130 participants
Long-Term Follow-Up of Recipient of Gene Transfer Research
- NCT01631617 · 130 participants · Phase 2
Effects of Treatments on Atopic Dermatitis
- NCT02368041 · 130 participants
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- NCT02604277 · 130 participants · NA
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI